Community, parental and adolescent awareness and knowledge of meningococcal diseaseBING WANG; CLARKE, Michelle; HOSSEIN HAJI ALI AFZALI et al.Vaccine. 2014, Vol 32, Num 18, pp 2042-2049, issn 0264-410X, 8 p.Article

Meningococcal carriage and disease―Population biology and evolutionCAUGANT, Dominique A; MAIDEN, Martin C. J.Vaccine. 2009, Vol 27, issn 0264-410X, B64-B70, SUP2Conference Paper

From secondary prevention to primary prevention : a unique strategy that gives hope to a country ravaged by meningococcal diseaseO'HALLAHAN, Jane; LENNON, Diana; OSTER, Philipp et al.Vaccine. 2005, Vol 23, Num 17-18, pp 2197-2201, issn 0264-410X, 5 p.Conference Paper

Psychiatric adjustment in the year after meningococcal disease in childhoodSHEARS, Daniel; NADEL, Simon; GLEDHILL, Julia et al.Journal of the American Academy of Child and Adolescent Psychiatry. 2007, Vol 46, Num 1, pp 76-82, issn 0890-8567, 7 p.Article

Actes. I/5ème Conférence internationale sur la méningite cérébrospinale, Le Pharo Marseille, 15-17 mars 1983 = Acta I. 5th International conference on cerebrospinal meningitis. Le Pharo-Marseille, 1983/3/15-17PICQ, J. J.Médecine tropicale. 1983, Vol 43, pp 7-108, issn 0025-682X, 99 p., h. ser. no 1Conference Proceedings

Conférence internationale sur la méningite cérébrospinale. 5, Le Pharo-Marseille, 15-17 mars 1983 = International conference on cerebrospinal meningitis Le Pharo Marseille 1983 Mars 15-17Médecine tropicale. 1983, Vol 43, pp 115-237, issn 0025-682X, h. sér. no 2Conference Proceedings

Severity of Meningococcal Disease Associated with Genomic Bacterial LoadDARTON, Tom; GUIVER, Malcolm; NAYLOR, Simone et al.Clinical infectious diseases. 2009, Vol 48, Num 5, pp 587-594, issn 1058-4838, 8 p.Article

Subtypin meningococciALLERBERGER, F; EIGENTLER, A; DIERICH, M. P et al.Lancet (British edition). 1992, Vol 339, Num 8785, issn 0140-6736, p. 125Article

Broadsheet 121: June 1989. Investigation of meningococcal diseaseCARTWRIGHT, K; JONES, D. M.Journal of clinical pathology. 1989, Vol 42, Num 6, pp 634-639, issn 0021-9746Article

Quantitation of endotoxin in blood from patients with meningococcal disease using a limulus lysate test in combination with chromogenic substrateHARTHUG, S; BJORVATN, B; OSTERUD, B et al.Infection. 1983, Vol 11, Num 4, pp 192-195, issn 0300-8126Article

Meningococcemia in genetically determined deficiency of the second component of complementLEGGIADRO, R. J; WARREN, A. B; SWIFT, A. J et al.The Journal of infectious diseases. 1983, Vol 148, Num 5, issn 0022-1899, 941Article

Meningococcal Disease Awareness: Clinical and Epidemiological Factors Affecting Prevention and Management in AdolescentsPELTON, Stephen I.Journal of adolescent health. 2010, Vol 46, Num 2, issn 1054-139X, S9-S15, SUPArticle

Adolescents and vaccines in the western worldPRINCIPI, Nicola; ESPOSITO, Susanna.Vaccine. 2013, Vol 31, Num 46, pp 5366-5374, issn 0264-410X, 9 p.Article

New Zealand's epidemic of meningococcal disease described using molecular analysis : implications for vaccine deliveryDYET, K; DEVOY, A; MCDOWELL, R et al.Vaccine. 2005, Vol 23, Num 17-18, pp 2228-2230, issn 0264-410X, 3 p.Conference Paper

The concept of tailor-made, protein-based, outer membrane vesicle vaccines against meningococcal diseaseHOLST, Johan; FEIRING, Berit; ALONSO, Jean-Michel et al.Vaccine. 2005, Vol 23, Num 17-18, pp 2202-2205, issn 0264-410X, 4 p.Conference Paper

Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all agesBRÖKER, Michael; DULL, Peter M; RAPPUOLI, Rino et al.Vaccine. 2009, Vol 27, Num 41, pp 5574-5580, issn 0264-410X, 7 p.Article

Changes in the evolution of meningococcal disease, 2001―2008, Catalonia (Spain)MARTINEZ, Ana I; DOMINGUEZ, Angela; OVIEDO, Manuel et al.Vaccine. 2009, Vol 27, Num 25-26, pp 3496-3498, issn 0264-410X, 3 p.Conference Paper

Evaluating the post-licensure effectiveness of a group B meningococca vaccine in New Zealand : a multi-faceted strategyAMERATUNGA, Shanthi; MACMILLAN, Alex; STEWART, Joanna et al.Vaccine. 2005, Vol 23, Num 17-18, pp 2231-2234, issn 0264-410X, 4 p.Conference Paper

Human toll-like receptor 4 mutations are associated with susceptibility to invasive meningococcal disease in infancyFABER, Joerg; MEYER, Claudius U; HABERMEHL, Pirmin et al.The Pediatric infectious disease journal. 2006, Vol 25, Num 1, pp 80-81, issn 0891-3668, 2 p.Article

MODERN TRENDS IN MORTALITY FROM MENINGOCOCCAL DISEASE IN AUSTRALIASIMPKINS, Daniel; WOOD, Nicholas; JELFS, Jane et al.The Pediatric infectious disease journal. 2009, Vol 28, Num 12, pp 1119-1120, issn 0891-3668, 2 p.Article

THE CLINICAL BURDEN AND PREDICTORS OF SEQUELAE FOLLOWING INVASIVE MENINGOCOCCAL DISEASE IN AUSTRALIAN CHILDRENBING WANG; CLARKE, Michelle; THOMAS, Natalie et al.The Pediatric infectious disease journal. 2014, Vol 33, Num 3, pp 316-318, issn 0891-3668, 3 p.Article

Early Estimate of the Effectiveness of Quadrivalent Meningococcal Conjugate VaccineMACNEIL, Jessica R; COHN, Amanda C; ZELL, Elizabeth R et al.The Pediatric infectious disease journal. 2011, Vol 30, Num 6, pp 451-455, issn 0891-3668, 5 p.Article

Complement and properidin deficiencies in meningococcal diseaseMATHEW, Susan; OVERTURF, Gary D.The Pediatric infectious disease journal. 2006, Vol 25, Num 3, pp 255-256, issn 0891-3668, 2 p.Article

Prevalence of deficits of complement components in patients with recurrent meningococcal infectionsMERINO, J; RODRIGUEZ-VALVERDE, V; LAMELAS, J. A et al.The Journal of infectious diseases. 1983, Vol 148, Num 2, issn 0022-1899, 331Article

Stability of PorA during a meningococcal disease epidemicDEVOY, A. F; DYET, K. H; MARTIN, D. R et al.Journal of clinical microbiology (Print). 2005, Vol 43, Num 2, pp 832-837, issn 0095-1137, 6 p.Article